Cancer Research UK’s (CRUK) ambition to beat cancer relies on a diverse and inclusive scientific workforce. People are at the…

For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research

Disrupted cell signalling, hijacked stem cells and the power of ‘mini-guts’ – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

Cancer Research Matters provokes conversation around cancer science, how it shapes our understanding of the disease and the challenges we face as we develop therapies.

Chief clinician Charlie Swanton gives some of his personal reflections on how far research has come and why sustained investment is so important for the therapies of the future.

Chief scientist Karen Vousden, contemplates the advances coming from cell biology and genomics and why the new frontiers of cancer research require a systems biology approach.

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

Two of our Research Committee Chairs take stock of the incredible science done over 2021 and tell us what they are excited about in the year to come

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers…

As the Government sets out proposals to reform data protection laws, what could this mean for researchers?